[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information to the Office of Management and Budget on a guidance on ...[ Price : $8.95]
FDA says Ariad has agreed to its request to suspend sales and marketing of Iclusig due to safety concerns.[ Price : $8.95]
FDA grants Stem Cell Therapeutics an orphan drug designation for the use of tigecycline in treating acute myeloid leukemia.[ Price : $8.95]
Actavis files an ANDA seeking approval to market a generic copy of Ranbaxys Absorica (isotretinoin) capsules, and the company is s...[ Price : $8.95]
AstraZeneca says it has received a civil investigative demand from the U.S. Department of Justice seeking documents and informatio...[ Price : $8.95]
FDA rescinds an Amarin study special protocol assessment agreement for Vascepa (icosapent ethyl) capsules after it determined that...[ Price : $8.95]
FDA grants KaloBios Pharmaceuticals an orphan drug designation for KB001-A, an anti-PcrV monoclonal antibody fragment for treating...[ Price : $8.95]
Attorney Stephen Sheller urges FDA to use its power to obtain documents on risperidone pediatric safety from Johnson & Johnson.